European Journal of Radiology
Volume 53, Issue 3 , Pages 514-519 , March 2005

Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue

  • Ansgar Rudisch

      Affiliations

    • Department of Radiology, University Hospital of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria, Europe
    • Corresponding Author InformationCorresponding author. Tel.: +43 512 504 2761; fax: +43 512 504 2758.
  • ,
  • Christian Kremser

      Affiliations

    • Department of Radiology, University Hospital of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria, Europe
  • ,
  • Werner Judmaier

      Affiliations

    • Department of Radiology, University Hospital of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria, Europe
  • ,
  • Hildegard Zunterer

      Affiliations

    • Department of Radiology, University Hospital of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria, Europe
  • ,
  • Alexander F. DeVries

      Affiliations

    • Department of Radiotherapy, University Hospital of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria, Europe

Received 20 February 2004 ,Revised 28 April 2004 ,Accepted 1 June 2004.

References 

  1. Silbergeld DL, Ali-Osman F. Isolation and characterization of microvessels from normal brain and brain tumors. J. Neurooncol. 1991;11(1):49–55
  2. Lichtenbeld HC, Barendsz-Janson AF, van Essen H, Struijker BH, Griffioen AW, Hillen HF. Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model. Int. J. Cancer. 1998;77(3):455–459
  3. Jain RK. Determinants of tumor blood flow: a review. Cancer Res. 1988;48(10):2641–2658
  4. Hopkins KL, Li KC, Bergman G. Gadolinium-DTPA-enhanced magnetic resonance imaging of musculoskeletal infectious processes. Skeletal Radiol. 1995;24(5):325–330
  5. Nishimura R, Takahashi M, Morishita S, Sumi M, Uozumi H, Sakamoto Y. MR Gd-DTPA enhancement of radiation brain injury. Radiat. Med. 1992;10(3):109–116
  6. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat. Med. 2003;9(6):713–725
  7. Debbage PL, Griebel J, Ried M, Gneiting T, DeVries A, Hutzler P. Lectin intravital perfusion studies in tumor-bearing mice: micrometer-resolution, wide-area mapping of microvascular labeling, distinguishing efficiently and inefficiently perfused microregions in the tumor. J. Histochem. Cytochem. 1998;46(5):627–639
  8. Jacobs RE, Cherry SR. Complementary emerging techniques: high-resolution PET and MRI. Curr. Opin. Neurobiol. 2001;11(5):621–629
  9. DeVries AF, Griebel J, Kremser C, Judmaier W, Gneiting T, Kreczy A, et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 2001;61(6):2513–2516
  10. DeVries A, Griebel J, Kremser C, Judmaier W, Gneiting T, Debbage P, et al. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology. 2000;217(2):385–391
  11. Deichmann R, Haase A. Quantification of T1 values by snapshot-FLASH-NMR-imaging. J. Magn. Reson. 1992;96:608
  12. Deichmann R, Hahn D, Haase A. Fast T1 mapping on a whole-body scanner. Magn. Reson. Med. 1999;42(1):206–209
  13. DeVries AF, Griebel J, Judmaier W, Kremser C, Gneiting T, Hoflehner J, et al. Development and application of dynamic MR-imaging for evaluation of perfusion changes in rectal carcinoma during fractionated radiotherapy in clinical use: primary results. Strahlenther Onkol. 1999;175:569–576
  14. Peters AM, Gunasekera RD, Henderson BL, Brown J, Lavender JP, De Souza M, et al. Noninvasive measurement of blood flow and extraction fraction. Nucl. Med. Commun. 1987;8(10):823–837
  15. Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br. J. Radiol. 1991;64(761):409–412
  16. International Commission on Radiation Units and Measurements. Tissue Substitutes, Phantoms and Computational Modeling in Medical Ultrasound. ICRU Report 61. 61, 44–46. 1999. International Commission on Radiation Units and Measurements, editors. Library of Congress Cataloging in Publication Data. Ref Type: Report.
  17. Wheeler RH, Ziessman HA, Medvec BR, Juni JE, Thrall JH, Keyes JW, et al. Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res. 1986;46(8):4200–4204
  18. McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002;62(18):5381–5385
  19. Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int. J. Radiat. Oncol. Biol. Phys. 1996;36(3):623–633
  20. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT—initial experience. Radiology. 1999;210(1):269–276
  21. Beets-Tan RG, Beets GL, Borstlap AC, Oei TK, Teune TM, von Meyenfeldt MF, et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI?. Abdom. Imag. 2000;25(5):533–541
  22. Lindner JR. Evolving applications for contrast ultrasound. Am. J. Cardiol. 2002;90(10 Suppl. 1):72–80
  23. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imag. 1999;10(3):223–232
  24. Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CM. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br. J. Cancer. 2000;83(5):620–625
  25. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J. Pathol. 1998;184(2):119–122
  26. Verstraete KL, Vanzieleghem B, De Deene Y, Palmans H, De Greef D, Kristoffersen DT, et al. Static, dynamic and first-pass MR imaging of musculoskeletal lesions using gadodiamide injection. Acta Radiol. 1995;36(1):27–36
  27. Kim S, Kim JH, Moon WK, Min BG. Lesion characterization using vessel permeability map to new blood pool contrast agent calculated from dynamic magnetic resonance images. J. Digit. Imag. 2000;13(2 Suppl. 1):193–195
  28. Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J. Magn. Reson. Imag. 1999;10(3):260–266

PII: S0720-048X(04)00190-1

doi: 10.1016/j.ejrad.2004.06.002

European Journal of Radiology
Volume 53, Issue 3 , Pages 514-519 , March 2005